Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

BMS 242 S2 Cell and Molecular > Molecular biology and the diagnosis and treatment of cancer > Flashcards

Molecular biology and the diagnosis and treatment of cancer Flashcards

1
Q

Cancer can be caused by:

A

physical carcinogens
chemical carcinogens
biological carcinogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

physical carcinogens:

A

ultraviolet and ionizing radiation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

chemical carcinogens:

A

asbestos and tobacco smoke.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

biological carcinogens:

A

infections from certain viruses, bacteria or parasites.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does HER stand for?

A

Human Epidermal Growth Factor Receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are HERs?

A

a family of structurally-related cell surface protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

4 HER families

A

HER1 (EGFR/ERB1)
HER2 (ERB2/NEU)
HER3 (ERB3)
HER4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the structure of HERs

A

Extracellular ligand-binding domain

Intracellular tyrosine kinase domain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What do HER proteins undergo? Which one if the exception?

A

HER proteins undergo a conformational change
upon ligand binding that is essential for dimerization and signaling

HER2 does not undergo this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What primes the receptor for activity?

A

The ligand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What happens once the ligand binds?

A

The receptor can either homo or heterodimerise.

This stimulates the receptor to signal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which pair has the strongest mitogenic signling?

A

HER2:HER3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mitogenesis

A

The induction (triggering) of mitosis, typically via a mitogen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mitogen and mechanism of action

A

A mitogen is a peptide or small protein, that induces a cell to begin cell division: mitosis.
It triggers signal transduction pathways involving mitogen-activated protein kinase (MAPK), leading to mitosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe HER signalling pathway

A

Ligand binding causes a conformational change which leads to dimerisation.

Dimerisation activates the tyrosine kinase domain.

HER2 is in a conformation which promotes dimerisation.

Different combinations of receptors stimulate different signaling pathways.

HER pathways stimulate cell proliferation, survival and are anti-apoptopic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Are HERs proto-oncogenes or tumor suppressor genes?

A

proto-oncogenes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How can HER become oncogenic?

A

Over expression

Mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What was published in 1984?

A

that a mutant form of HER2 (neu) promotes cancer in rats.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is different about HER2 from the others and what can this lead to

A

HER2 doesn’t need a ligand – always in an active state, always ready to signal

why we get overexpression of protein and start to get cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Where is the HER2 gene frequently amplified?

A

in breast cancer samples

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What can happen when DNA replication goes wrong?

A

The cell can
end up with hundreds of
copies of a gene (gene
amplification).

Normal
cells are diploid so 2n (2
copies of a gene).

22
Q

What happens when DNA replication goes wrong in a proto-oncogene?

A

If the gene is a protooncogene like HER2 this

can promote cancer.

23
Q

What technique can be used to determine copy number of a gene?

A

Fluorescence in situ

hybridisation (FISH)

24
Q

Gene amplification of HER2 leads to

A

increased levels of the receptor

25
Q

Difference in number of HER2 per cell in normal breast tissue and cancerous breast tissue

A

Normal breast tissue has approximately 20,000 copies of the HER2 per cell.

Cancerous tissue can have up to 2 million copies per cell.

26
Q

HER2 as a marker

A

HER2 is a negative prognostic marker for several cancers

27
Q

Over expression of HER2 correlates with.

A

Over expression of HER2 correlates with poor survival rates.

28
Q

Median survival for breast cancer patients without treatment

A

(HER2 positive 3 years)

HER2 normal 6-7 years

29
Q

What is HER2 positive cancer

A

25% HER2 overexpressed

can do little when HER2 positive compared to HER2 normal

30
Q

How did Genetech target HER2 overexpression in breat cancer?

A

using therapeutic antibodies

31
Q

Advantages of using antibodies

A

Antibodies can be raised against nearly any protein.

Antibodies are very specific.

Antibody binding can interfere with receptor signaling.

Antibody binding can target cells for destruction by the
bodies immune system.

32
Q

First step in process of making therapeutic antibodies?

A

making a monoclonal antibody.

33
Q

Monoclonal antibodies

A

Recognise a single epitope

on an antigen.

34
Q

Disadvantage to monoclonal antibodies?

A

murine antibodies are not well tolerated in humans (Muromonab-CD3 1986).

35
Q

How was the disadvantage to monoclonal antibodies solved?

A

This problem is solved by a process called humanisation.

36
Q

What inhibits HER2 growth

A

Targeting HER2 over expressing cancer

cells with 4D5

37
Q

Method of targeting HER2 over expression with 4D5

A

1) Treating HER2 over expressing cells with the monoclonal antibody
(4D5) which binds the extracellular domain of HER2 inhibits their proliferation.
2) Injecting mice with the anti-HER2 monoclonal (4D5) antibody suppresses tumor growth in mice.
3) Injected radio labeled 4D5 targets HER2 positive breast cancer cells in women.

38
Q

humanised version of 4D5

A

Herceptin (Trastuzumab)

39
Q

An IgG1 molecule consists

A

of 2 heavy chains and 2 light chains.

40
Q

Hypervariable regions of the antibody

what are these regions also called?

A

Involved in antigen binding.

These regions are also called
complementary determining regions
(CDRs).

41
Q

How many CDRs can be involved in binding an antigen?

A

Up to six CDRs can be involved in binding

an antigen.

42
Q

Method of how humanised version of 4D5 Herceptin generated?

A

1) Clone the murine heavy and light chain cDNA encoding 4D5.
2) Clone the murine CDRs of 4D5 into human IgG1 heavy chain and light chain plasmids.
3) The humanised antibody is then made by transfecting CHO cells with light chain and heavy chain plasmids

43
Q

Phase II clinical trials of Herceptin

A

Study shows that Herceptin is active on women with HER2 positive breast cancer.
However, it did not show any benefit on women who had normal levels of HER2.

44
Q

Phase III clinical trials of Herceptin

A

Phase 3 clinical trial shows that women with HER2 positive breast cancer gain an
extra 5 months disease free survival. However, Herceptin can cause serious complications.
Cancer returns in the majority of the women.

45
Q

in 1998 what does the FDA approve?

A

Herceptin for the treatment of women with metastatic
breast cancer who have tumors that over express HER2. In 2000 the European Commission
approve Herceptin.

46
Q

More clinical trails performed two

A
  • investigate the best way to use Herceptin

- Determine if Herceptin works on other HER2 positive cancers (indications)

47
Q

Herceptin is most effective

A

if it is used in combination with surgery or chemotherapy (adjuvant therapy).
1 year of treatment.

48
Q

What cancer is Herceptin also approved for?

A

Approved for use in metastatic gastric cancer.

49
Q

Future directions

A

HER2 dimerisation inhibitors
Antibody drug conjugates
Targeting other HER family members
Drug combinations

50
Q

Drug combinations

A

Giving Herceptin plus tyrosine kinase inhibitor (Tyverb) got rid of HER2 positive tumors within 11 days.

51
Q

Women with normal levels of HER2 will respond to Herceptin? True or False

A

False

52
Q

Cancer will come back in 15-25% of women treated with Herceptin?
True or False?

A

True

BMS 242 S2 Cell and Molecular (3 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions